<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20190618043930N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-11-13</date_registration>
      <primary_sponsor>The University of Lahore</primary_sponsor>
      <public_title>Chronic Cervical Myofascial Pain Syndrome</public_title>
      <acronym></acronym>
      <scientific_title>Comparative Effects of Low-Level Laser Acupuncture and Dry Needling on Clinical and Functional Outcomes in Patients with Chronic Cervical Myofascial Pain Syndrome</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-11-25</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>80</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/72437</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Random Allocation Software version 2 will be used for Block randomization design to allocate participants to the groups with an equal sample size over time. The groups will be labeled (E= experimental, C= control). Then a block size of four will chose.So, there will be six possible ways to equally assign participants to a block (EECC, ECEC, ECCE, CEEC, CECE, CCEE). Blocks will be randomly chosen to determine the assignment of all 80 individuals (40 participants in each group). Allocation concealment will be performed using sealed, opaque envelopes, Blinding description: The treatment procedures will be repeated for 3 sessions per week for 6 weeks (18 sessions). The Pre-test, Mid-test &amp; Post-test scores of Numeric Pain Rating Scale, Neck Disability Index, Goniometer and SF-36 Questionnaire will be collected and analysed by an outcome Assessor, who will be kept blind throughout the session in order to reduce any biasing in the study.</study_design>
      <phase>2</phase>
      <hc_freetext>Myofascial pain syndrome is a frequently encountered musculoskeletal problem characterized by a hypersensitive trigger point. Symptoms of myofascial pain syndrome include pain and increased pain threshold, muscle spasms, and range of motion (ROM) limitation. The symptoms affect quality of life, decrease productivity, reduce work time, and increase the medical expenses borne by the patient. Myofascial pain syndrome frequently occurs in the upper body, with 84% of the trigger points found in the trapezius, scalene, levator scapulae, and infraspinatus muscles. The trapezius muscle is the most frequent site, being involved in 34% of cases. The development of myofascial pain syndrome is related to excessive repetitive activity. Activities that cause muscle tension and fatigue, poor posture, and poor ergonomic work environment are likely to be involved..</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:Participants treated by Low-Level Laser acupuncture will be given goggles for eye protection. The trigger points on the Scalene, Levator scapulae and Trapezius muscles will be marked with an 'X' mark. The laser probe (01 cm in diameter) with the power output of 100mv/cm2, the frequency of 9.12 hz that emits a laser beam with 830 nm will be applied directly and perpendicularly into the skin. The irradiation dosage will be 5J/cm2 at each trigger point for Six minutes. The stretching of the Cervical ROM will be done at the end of a session. Intervention 2: Control group: In Dry needling group, while the patient is in prone position, the therapist will wear the surgical gloves, sterilize the area with alcohol pad and use pincer palpation to identify the trigger points. A 25G acupuncture needle (0.3* 30 mm) will be placed on the trigger point to a depth of 2cm. The insertion site will be monitored for local twitch responses (LTRs) for a maximum of 30 minutes with manipulation of the needle until no LTRs will be seen. The needles will be removed and any bleeding that occurre will be controlled. The stretching of the cervical ROM will be done at end of the session.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Consent form, Clinical Study Report, Statistical Plan files
can be shared

When:
2 months after Publication

To whom:
People working in academic institutions or people
working in businesses can also apply to receive it

Conditions:
Intervention Purpose

Where to obtain:
faryal.pt@gmail.com

How to obtain:
Full description about the purpose/aim of using the documents, Insight about the disorder and Intervention of the research

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr. Faryal Zaidi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>1-Km Defence Road, Off Bhobatian Chowk</address>
        <city>Lahore</city>
        <country1>Pakistan</country1>
        <zip>54590</zip>
        <telephone>+92 42 35322501</telephone>
        <email>faryal.pt@gmail.com</email>
        <affiliation>The University of Lahore</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Faryal Zaidi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>1-Km Defence Road, Off Bhobatian Chowk</address>
        <city>Lahore</city>
        <country1>Pakistan</country1>
        <zip>54590</zip>
        <telephone>+92 42 35322501</telephone>
        <email>faryal.pt@gmail.com</email>
        <affiliation>The University of Lahore</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Newly diagnosed cases of chronic MyofasciaL Pain Syndrome of Cervical Spine,
Patients with at least moderate score (21% - 40%) in Neck Disability Index,
Patients with at least &gt;3 points on Numeric Pain Rating Scale,
Decreased Cervical Range of Motion up to sixty percent.
Bilateral/Unilateral neck pain and Myofascial Trigger Points in upper trapezius, levator scapulae or scalene muscles for at least three months,
Taught muscle band and positive Jump Sign on putting finger pressure on the trigger point.</inclusion_criteria>
      <agemin>25 years</agemin>
      <agemax>50 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients receiving treatment by other methods like vapocoolants, subdural steroid injections etc.
Cervical spine surgery within the past year
Spondylolisthesis and Ankylosing spondylitis
Vascular, neurological or rheumatic disorders
Clinical evidence of any myelopathy or joint disorders
Recent fracture of the cervical spine
Cauda equina syndrome
Osteoporosis
Fibromyalgia
Clinical evidence of any tumor or any space occupying lesion.
Any co-morbid diseases</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M79.12</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Myalgia of Auxiliary muscles, head and neck</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:Participants treated by Low-Level Laser acupuncture will be given goggles for eye protection. The trigger points on the Scalene, Levator scapulae and Trapezius muscles will be marked with an 'X' mark. The laser probe (01 cm in diameter) with the power output of 100mv/cm2, the frequency of 9.12 hz that emits a laser beam with 830 nm will be applied directly and perpendicularly into the skin. The irradiation dosage will be 5J/cm2 at each trigger point for Six minutes. The stretching of the Cervical ROM will be done at the end of a session.</i_keyword>
      <i_keyword>Control group: In Dry needling group, while the patient is in prone position, the therapist will wear the surgical gloves, sterilize the area with alcohol pad and use pincer palpation to identify the trigger points. A 25G acupuncture needle (0.3* 30 mm) will be placed on the trigger point to a depth of 2cm. The insertion site will be monitored for local twitch responses (LTRs) for a maximum of 30 minutes with manipulation of the needle until no LTRs will be seen. The needles will be removed and any bleeding that occurre will be controlled. The stretching of the cervical ROM will be done at end of the session.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain Intensity. Timepoint: At the start of treatment and then after 9th and 18th treatment session. Method of measurement: Numeric Pain Rating Scale.</prim_outcome>
      <prim_outcome>Functional disability. Timepoint: At the start of treatment and then after 9th and 18th treatment session. Method of measurement: Neck Disability Index.</prim_outcome>
      <prim_outcome>Cervical Range of Motion. Timepoint: At the start of treatment and then after 9th and 18th treatment session. Method of measurement: Goniometer.</prim_outcome>
      <prim_outcome>Quality of Life. Timepoint: At the start of treatment and then after 9th and 18th treatment session. Method of measurement: SF-36 Questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>The University of Lahore</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-06-19</approval_date>
        <contact_name>Board of Advanced Studies and Research, The University of Lahore</contact_name>
        <contact_address>1-km Defence Road, Off Bhobatian Chowk Lahore Punjab Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
